GENE ONLINE|News &
Opinion
Blog

2021-02-21| IPOSpecial

BIOCEO21 Highlights: Criteria for Successful Launches of Biotech SPACs

by Daniel Ojeda
Share To
When a company enters the stock market, it allows the public to trade its shares. An Initial Public Offering (IPO) allows companies to offer new stocks to the investors and raise capital. Well-funded companies can do a direct listing, which allows them to sell existing shares and avoid the cost of a traditional IPO. However, it doesn’t let them raise more capital. Over the last few years, Special Purpose Acquisition Company (SPAC) has become a more popular route to IPO.

It's free! Log in now to read

LATEST
Innovative Cellular Mapping of BRCA-Related Breast Cancer Findings Reveals Novel Therapeutic Targets
2024-03-29
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top